Imap

Imap - General Information

A long-acting injectable antipsychotic agent used for chronic schizophrenia.

Pharmacology of Imap

Imap is a relatively long-acting injectable depot antipsychotic drug used for schizophrenia. Imap does not differ greatly from other depot antipsychotics (fluphenazine decanoate, fluphenazine enathate, perphenazine onanthat, pipotiazine undecylenate) with respect to treatment efficacy, response or tolerability. Outcomes suggest that fluspirilene does not differ significantly from oral antipsychotics or in different weekly regimens, although much cannot be inferred because of the shortage of trials.

Additional information about Imap

Imap Indication: Used for the treatment of schizophrenia.
Mechanism Of Action: Not Available
Drug Interactions: Not Available
Food Interactions: Avoid alcohol.
Generic Name: Fluspirilene
Synonyms: Fluspirileno [inn-spanish]; Fluspirilenum [inn-latin]
Drug Category: Antipsychotic Agents; Dopamine Antagonists
Drug Type: Small Molecule; Approved

Other Brand Names containing Fluspirilene: Imap; Lopac-F-100; Redeptin;
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Imap: Solution Intramuscular
Chemical IUPAC Name: 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Chemical Formula: C29H31F2N3O
Fluspirilene on Wikipedia: https://en.wikipedia.org/wiki/Fluspirilene
Organisms Affected: Humans and other mammals